ES511329A0 - "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales". - Google Patents

"procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".

Info

Publication number
ES511329A0
ES511329A0 ES511329A ES511329A ES511329A0 ES 511329 A0 ES511329 A0 ES 511329A0 ES 511329 A ES511329 A ES 511329A ES 511329 A ES511329 A ES 511329A ES 511329 A0 ES511329 A0 ES 511329A0
Authority
ES
Spain
Prior art keywords
imidazotiazole
derivatives
salts
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511329A
Other languages
English (en)
Other versions
ES8307826A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kumiai Chemical Industry Co Ltd
Toyo Jozo KK
Original Assignee
Kumiai Chemical Industry Co Ltd
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumiai Chemical Industry Co Ltd, Toyo Jozo KK filed Critical Kumiai Chemical Industry Co Ltd
Publication of ES8307826A1 publication Critical patent/ES8307826A1/es
Publication of ES511329A0 publication Critical patent/ES511329A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES511329A 1981-04-10 1982-04-08 "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales". Granted ES511329A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56054166A JPS57169490A (en) 1981-04-10 1981-04-10 2,3-disubstituted-5,6-dihydro-imidazo(2,1-b)thiazole, its salt and their preparation

Publications (2)

Publication Number Publication Date
ES8307826A1 ES8307826A1 (es) 1983-07-01
ES511329A0 true ES511329A0 (es) 1983-07-01

Family

ID=12962957

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511329A Granted ES511329A0 (es) 1981-04-10 1982-04-08 "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".

Country Status (10)

Country Link
US (2) US4556669A (es)
JP (1) JPS57169490A (es)
CA (1) CA1175842A (es)
CH (1) CH648319A5 (es)
DE (1) DE3213027A1 (es)
ES (1) ES511329A0 (es)
FR (1) FR2503713B1 (es)
GB (1) GB2099419B (es)
IT (1) IT1190764B (es)
NL (1) NL8201525A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1271480A (en) * 1985-04-22 1990-07-10 Toyo Jozo Co., Ltd. 5,6-dihydroimidazo[2,1-b]thiazole-2-carboxamide derivatives or salts thereof
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
GB0404434D0 (en) 2004-02-27 2004-03-31 Novartis Ag Organic compounds
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041167A (en) * 1976-01-19 1977-08-09 Diamond Shamrock Corporation Antiinflammatory imidazothiazoles
GB1556877A (en) * 1976-01-19 1979-11-28 Diamond Shamrock Corp Imidazothiazoles and thiazolopyrimidines

Also Published As

Publication number Publication date
FR2503713A1 (fr) 1982-10-15
NL8201525A (nl) 1982-11-01
ES8307826A1 (es) 1983-07-01
DE3213027A1 (de) 1983-01-27
GB2099419B (en) 1985-01-09
IT8220644A0 (it) 1982-04-08
US4629793A (en) 1986-12-16
GB2099419A (en) 1982-12-08
US4556669A (en) 1985-12-03
CH648319A5 (it) 1985-03-15
IT1190764B (it) 1988-02-24
CA1175842A (en) 1984-10-09
FR2503713B1 (fr) 1985-07-05
JPS57169490A (en) 1982-10-19

Similar Documents

Publication Publication Date Title
ES511955A0 (es) "procedimiento para la preparacion de derivados de cefem".
ES512067A0 (es) "procedimiento para la preparacion de derivados de eter arilfenilico".
ES509848A0 (es) "procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2-"
ES512259A0 (es) "procedimiento para la preparacion de nuevos derivados piperidinicos piperacinicos y homopiperacinicos".
AR240806A1 (es) Procedimiento para la elaboracion de acidos 3-amino-(1)benzazepin- 2-ona-1-alcanoicos y sus sales.
ES515301A0 (es) "procedimiento para la preparacion de derivados de urea".
ES510348A0 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
ES509693A0 (es) Derivados de carbostirilo y sus sales.
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
AR222828A1 (es) Procedimiento para la preparacion de 2,3,4,5-tetrahidro-6-feniltio-1h-3-benzazepinas y sus sales
ES551538A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidro-4-oxonaftiridina y sus sales
ES515104A0 (es) "procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina".
ES510888A0 (es) "procedimiento para la produccion de derivados de 1-aril-2-azolileteno".
ES515728A0 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
ES546619A0 (es) Derivados de 2,3-dihidro-1h-indeno y sus sales
ES513846A0 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
AR240918A1 (es) "procedimiento para obtener novedosos derivados de carboestirilo y sus sales."
AR240924A1 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
ES511329A0 (es) "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".
ES510908A0 (es) "un procedimiento para la preparacion de derivados de piridinona".
ES513619A0 (es) "procedimiento para la preparacion de derivados de 1-azolil-2-hidroxi-alcano".
ES508293A0 (es) "procedimiento para la preparacion de derivados de tiazolina".